ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Polymer Platinate Begins Testing In Phase I Trial.

September 29, 2000

Women Who Received CMF Chemotherapy Score Lower On Cognitive Skill Exams

March 30, 2012

Obituary: Connie Curran, 67, C-Change Executive Director

November 21, 2014

Major New Grant Programs Approved In Carcinogenesis, Chemoprevention

May 9, 1980

In Brief: House Budget Committee Proposes 5% Cut To NIH In FY96; Steady Reductions Expected

March 24, 1995

Agreement Reached On Most CCOP Issues; First RFA To Be Out March, Awards To Be Made In Fiscal 1983

January 22, 1982